Neuronetics (NASDAQ: STIM) backer spent about $20.7M of his own cash

Rhea-AI Filing Summary

Neuronetics, Inc. (STIM) discloses that investor Jorey Chernett has updated his Schedule 13D filing in Amendment No. 4. The amendment primarily reflects a revised ownership percentage resulting from a change in Neuronetics’ outstanding common shares as reported in its August 11, 2026 Form 10-Q.

As of August 5, 2026, Neuronetics had 76,197,222 common shares outstanding, and Chernett beneficially owned 10,602,988 shares, representing approximately 13.92% of the company’s common stock. The filing states that these shares were acquired using personal funds for an aggregate purchase price of approximately $20,726,476. Chernett reports sole voting and dispositive power over the 10,602,988 shares and no shared power. Additional transaction details since the prior amendment are referenced in an exhibit.

Key Figures

Shares beneficially owned: 10,602,988 shares Percent of class: 13.92% Shares outstanding: 76,197,222 shares +3 more

6 metrics

Shares beneficially owned 10,602,988 shares Beneficial ownership reported by Jorey Chernett as of the amendment date

Percent of class 13.92% Portion of Neuronetics common stock beneficially owned by Jorey Chernett

Shares outstanding 76,197,222 shares Neuronetics common shares outstanding as of August 5, 2026

Aggregate purchase price $20,726,476 Approximate total personal funds used by Chernett to purchase 10,602,988 shares

Sole voting power 10,602,988 shares Shares over which Chernett has sole power to vote or direct the vote

Sole dispositive power 10,602,988 shares Shares over which Chernett has sole power to dispose or direct disposition

Key Terms

beneficially owned, sole voting power, sole dispositive power, Schedule 13D

4 terms

beneficially owned financial

"As of the close of business on the date hereof, the Reporting Person beneficially owned 10,602,988 Shares."

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole voting power financial

"Sole power to vote or direct vote: 10,602,988"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

sole dispositive power financial

"Sole power to dispose or direct the disposition: 10,602,988"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Schedule 13D regulatory

"This Amendment No. 4 to ("Amendment No. 4") amends and supplements the initially filed by the Reporting Person"

A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.

FAQ

How many Neuronetics (STIM) shares does Jorey Chernett currently beneficially own?

Jorey Chernett beneficially owns 10,602,988 shares of Neuronetics common stock. This ownership is reported in Amendment No. 4 to his Schedule 13D and reflects his position as of the close of business on the date of the amendment.

What percentage of Neuronetics (STIM) does Jorey Chernett own according to this Schedule 13D/A?

According to the amended Schedule 13D, Jorey Chernett beneficially owns approximately 13.92% of Neuronetics’ outstanding common stock, based on 76,197,222 shares outstanding as of August 5, 2026.

How were Jorey Chernett’s Neuronetics (STIM) shares financed?

The filing states that the 10,602,988 Neuronetics shares held by Jorey Chernett were purchased with personal funds for an aggregate purchase price of approximately $20,726,476.

Does Jorey Chernett have sole or shared voting power over his Neuronetics (STIM) shares?

Jorey Chernett reports sole voting power over 10,602,988 Neuronetics shares and no shared voting power. He also reports sole power to dispose or direct the disposition of the same number of shares, with no shared dispositive power.

Why was Amendment No. 4 to the Schedule 13D for Neuronetics (STIM) filed?

Amendment No. 4 was filed primarily to update the ownership percentage reported for Jorey Chernett, reflecting changes in Neuronetics’ outstanding shares disclosed in its Form 10-Q filed on August 11, 2026. Other terms of the prior Schedule 13D remain in effect.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 08:03 PM Accepted by SEC EDGAR 08/24/2026 - 08:03 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 4)

Neuronetics, Inc.

(Name of Issuer)

Common Stock, $0.01 par value

(Title of Class of Securities)

64131A105

(CUSIP Number)

Jorey Chernett
6222 Indianwood Tr.,
Bloomfield Hills, MI, 48301
(248) 469-8811

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

08/14/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): 64131A105

1

Name of reporting person

Chernett Jorey

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 10,602,988.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 10,588,988.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

10,602,988.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

13.92 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock, $0.01 par value
(b)	Name of Issuer: Neuronetics, Inc.
(c)	Address of Issuer's Principal Executive Offices: 3222 PHOENIXVILLE PIKE, MALVERN, PENNSYLVANIA , 19355.
Item 1 Comment: This Amendment No. 4 to Schedule 13D ("Amendment No. 4") amends and supplements the Schedule 13D initially filed by the Reporting Person on March 31, 2026, as subsequently amended (the "Schedule 13D") with respect to the Shares. The filing of this Amendment No. 4 is being made primarily to reflect the Reporting Person's current ownership percentage resulting from a change in the Issuer's outstanding shares, as reported in the Issuer's Quarterly Report on Form 10-Q filed on August 11, 2026. Except as specifically amended and supplemented hereby, the Schedule 13D remains in full force and effect. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Schedule 13D.
Item 3.	Source and Amount of Funds or Other Consideration
	Item 3 is hereby amended and restated as follows: The 10,602,988 Shares held by Mr. Chernett were purchased with personal funds for an aggregate purchase price of approximately $20,726,476.
Item 5.	Interest in Securities of the Issuer
(a)	Item 5(a) is hereby amended and restated as follows: The aggregate percentage of Shares beneficially owned by the Reporting Person is based upon 76,197,222 Shares outstanding as of August 5, 2026, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed with the U.S. Securities and Exchange Commission (the "SEC") on August 11, 2026. As of the close of business on the date hereof, the Reporting Person beneficially owned 10,602,988 Shares. Percentage: Approximately 13.92%
(b)	Item 5(b) is hereby amended and restated as follows: 1. Sole power to vote or direct vote: 10,602,988 2. Shared power to vote or direct vote: 0 3. Sole power to dispose or direct the disposition: 10,602,988 4. Shared power to dispose or direct the disposition: 0
(c)	Item 5(c) is hereby amended and restated as follows: The transactions in the Shares by the Reporting Person since the filing of Amendment No. 3 to the Schedule 13D are set forth in more detail in Exhibit 1 attached hereto.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Chernett Jorey

Signature:	/s/ Jorey Chernett
Name/Title:	Jorey Chernett
Date:	08/24/2026